Ulcerative Colitis news | Breaking ulcerative colitis news | Ulcerative Colitis

Lick the sugar problem

...DEADLY SOLUTIONS The food industry, therefore, created a 'solution' for the problem.

They invented artificial sweeteners.The first was saccharin.

It is a sweetener that causes cancer in animals.

Scientists have concluded that saccharin may also cause cancer in humans, but it took a long time for the health authorities to begin to advise the public on its negative effects.

ARTIFICIAL SWEETENER Later, an American company called Montsano invented another artificial sweetener called Aspartame.

It is marketed in Jamaica and the rest of the world as NutraSweet or Equal.

It is the sweetener that is found in many so-called diet drinks, such as Diet Coke and Diet Pepsi.

Diabetics and people who are trying to lose weight are particularly attracted to these artificial sweeteners because of their low-calorie content.

Today there are over 5,000 products that contain Aspartame.Aspartame is a dangerous and poisono...

Drugs formerly contraindicated for inflammatory bowel disease ...

...Study findings show that NSAIDs were well-tolerated, with COX-2 inhibitors offering the most effective pain relief in this group.

"In the past, physicians have considered These studies represent an important advance for patients with inflammatory bowel disease and their gastroenterologists searching for safe medications to help with pain relief," said Joshua R.

Korzenik, MD, author of an accompanying editorial from Massachusetts General Hospital in Boston.

"Patients with However, some researchers have argued that these painkillers have negative effects on IBD patients in remission.

According to a study in this month's issue of Clinical Gastroenterology and Hepatology, patients with IBD who use NSAIDs tolerate the drugs well and less than one in three patients experiences a flare-up in symptoms.

Furthermore, the study shows COX-2 inhibitors, previously thought to cause symptom recurrence in IBD patients, significantly reduce the likelihood of disease relapse.

To date, this is the most comprehensive study to address the effects of NSAID...

Shire seeks approval for its ulcerative colitis drug in Europe

...Email this page Your comments Shire seeks approval for its

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news

Health and Fitness   Health Living